These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12806161)

  • 1. Nebivolol ameliorates nitric oxide deficient hypertension.
    Fortepiani LA; Ortíz MC; Atucha NM; García-Estañ J
    ScientificWorldJournal; 2002 Jun; 2():1676-84. PubMed ID: 12806161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nebivolol, a novel beta 1-selective adrenoceptor antagonist with vasodilating properties, on kidney function.
    Greven J; Gabriëls G
    Arzneimittelforschung; 2000 Nov; 50(11):973-9. PubMed ID: 11148863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tempol-nebivolol therapy potentiates hypotensive effect increasing NO bioavailability and signaling pathway.
    Bertera FM; Santa-Cruz DM; Balestrasse KB; Gorzalczany SB; Höcht C; Taira CA; Polizio AH
    Free Radic Res; 2014 Feb; 48(2):109-18. PubMed ID: 24074298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collaborative therapy with nebivalol and L-NAME for spinal cord ischemia/reperfusion injury.
    Seren M; Budak B; Turan N; Parlar AI; Akar F; Ulus AT
    Ann Vasc Surg; 2008; 22(3):425-31. PubMed ID: 18466820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric-oxide-mediated relaxations in salt-induced hypertension: effect of chronic beta1 -selective receptor blockade.
    Cosentino F; Bonetti S; Rehorik R; Eto M; Werner-Felmayer G; Volpe M; Lüscher TF
    J Hypertens; 2002 Mar; 20(3):421-8. PubMed ID: 11875309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective actions of nebivolol on chronic nitric oxide synthase inhibition-induced hypertension and chronic kidney disease in the rat: a comparison with angiotensin II receptor blockade.
    Moningka NC; Tsarova T; Sasser JM; Baylis C
    Nephrol Dial Transplant; 2012 Mar; 27(3):913-20. PubMed ID: 21856762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantioselective pharmacokinetics and cardiovascular effects of nebivolol in L-NAME hypertensive rats.
    Bertera FM; Del Mauro JS; Lovera V; Chiappetta D; Polizio AH; Taira CA; Höcht C
    Hypertens Res; 2014 Mar; 37(3):194-201. PubMed ID: 24132009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic functions in NG-nitro-L-arginine-methyl-ester-induced hypertension: modulation by the renin-angiotensin system.
    K-Laflamme A; Foucart S; Moreau P; Lambert C; Cardinal R; de Champlain J
    J Hypertens; 1998 Jan; 16(1):63-76. PubMed ID: 9533419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vasodilatory beta-adrenoceptor antagonists on endothelium-derived nitric oxide release in rat kidney.
    Kakoki M; Hirata Y; Hayakawa H; Nishimatsu H; Suzuki Y; Nagata D; Suzuki E; Kikuchi K; Nagano T; Omata M
    Hypertension; 1999 Jan; 33(1 Pt 2):467-71. PubMed ID: 9931149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of blood pressure salt-sensitivity supports a preglomerular site of action of nitric oxide in Type I diabetic rats.
    Brands MW; Bell TD; Fleming C; Labazi H; Sturgis LC
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):475-9. PubMed ID: 17439418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebivolol alleviates aortic remodeling through eNOS upregulation and inhibition of oxidative stress in l-NAME-induced hypertensive rats.
    Wang Y; Zhang F; Liu Y; Yin S; Pang X; Li Z; Wei Z
    Clin Exp Hypertens; 2017; 39(7):628-639. PubMed ID: 28640644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of nitric oxide in both central and peripheral haemodynamic effect of D/L-nebivolol and its enantiomers in rats.
    Sacco G; Evangelista S; Criscuoli M; Goso C; Bigioni M; Binaschi M; Manzini S; Maggi CA
    Eur J Pharmacol; 2005 Mar; 511(2-3):167-74. PubMed ID: 15792785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic Antihypertensive Effect of Carthamus tinctorius L. Extract and Captopril in L-NAME-Induced Hypertensive Rats via Restoration of eNOS and AT₁R Expression.
    Maneesai P; Prasarttong P; Bunbupha S; Kukongviriyapan U; Kukongviriyapan V; Tangsucharit P; Prachaney P; Pakdeechote P
    Nutrients; 2016 Feb; 8(3):122. PubMed ID: 26938552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic arterial pressure response to two weeks of Tempol therapy in SHR: involvement of NO, the RAS, and oxidative stress.
    Yanes L; Romero D; Iliescu R; Cucchiarelli VE; Fortepiani LA; Santacruz F; Bell W; Zhang H; Reckelhoff JF
    Am J Physiol Regul Integr Comp Physiol; 2005 Apr; 288(4):R903-8. PubMed ID: 15604302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide inhibition and renal alterations.
    Jover B; Mimran A
    J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S65-70. PubMed ID: 11811381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebivolol: endothelium-mediated vasodilating effect.
    Ritter JM
    J Cardiovasc Pharmacol; 2001 Dec; 38 Suppl 3():S13-6. PubMed ID: 11811387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebivolol: a review of its use in the management of hypertension and chronic heart failure.
    Moen MD; Wagstaff AJ
    Drugs; 2006; 66(10):1389-409; discussion 1410. PubMed ID: 16903772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic dose of nebivolol, a nitric oxide-releasing beta-blocker, reduces atherosclerosis in cholesterol-fed rabbits.
    de Nigris F; Mancini FP; Balestrieri ML; Byrns R; Fiorito C; Williams-Ignarro S; Palagiano A; Crimi E; Ignarro LJ; Napoli C
    Nitric Oxide; 2008 Aug; 19(1):57-63. PubMed ID: 18435936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cellular mechanisms involved in the vasodilator effect of nebivolol on the renal artery.
    Georgescu A; Pluteanu F; Flonta ML; Badila E; Dorobantu M; Popov D
    Eur J Pharmacol; 2005 Jan; 508(1-3):159-66. PubMed ID: 15680267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
    Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.